Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-01-30 9:25 pm | N/A N/A | Metsera Inc. | MTSR | ARCH Venture Partners XII LLC ARCH Venture Fund XII L.P. ARCH Venture Partners XII L.P. ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 0 | $0 | 24,594,586 (Indirect) | View |
Ownership | 2025-01-30 4:42 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 37,588,634 (Indirect) | View |
| 2024-06-06 Option Award(A) | 2024-07-15 4:12 pm | N/A 2034-06-05 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:41 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 130,000 | $0 | 36,542,716 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:59 pm | N/A 2034-06-12 | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-06-10 Conversion | 2024-06-10 7:46 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 35,652,876 | $0 | 3,728,738 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-07 4:22 pm | N/A 2034-06-05 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 54,278 | $0 | 54,278 (Direct) | View |
Ownership | 2024-06-06 7:14 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 3,728,738 (Indirect) | View |
| 2024-05-30 Option Award | 2024-06-03 12:14 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director | 24,000 | $0 | 13,550,704 (Direct) | View |
| 2024-04-02 Conversion | 2024-04-04 4:30 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 4,851,442 | $0 | 1,181,766 (Indirect) | View |
Ownership | 2024-03-27 7:56 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 0 | $0 | 2,494,095 (Indirect) | View |
| 2023-12-08 Other | 2023-12-12 7:53 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 1,879,654 | $0 | 32,424,564 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-20 06:16 am | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 17,424,704 | $0 | 3,624,143 (Indirect) | View |
Ownership | 2023-09-14 9:29 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 0 | $0 | 28,045,420 (Indirect) | View |
| 2023-09-08 Option Award | 2023-09-08 4:24 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 55,000 | $0 | 36,467,716 (Direct) | View |
| 2023-07-28 Other | 2023-08-10 8:27 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $0 | 2,250,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 4:49 pm | N/A 2033-06-15 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 36,477,716 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:49 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 5:42 pm | N/A 2033-06-07 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-24 4:16 pm | 2024-05-22 2033-05-21 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 18,081 | $0 | 13,538,758 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 4:19 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 536 | $0 | 44,056,353 (Direct) | View |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 41,410,655 | $0 | 16,080 (Indirect) | View |
Ownership(A) | 2022-10-24 4:40 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 16,080 (Indirect) | View |
Ownership | 2022-10-19 8:03 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-10-05 Option Award | 2022-10-06 4:06 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 321 | $0 | 44,055,817 (Direct) | View |
| 2022-09-02 Other | 2022-09-07 8:30 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,333 | $0 | 1,662,347 (Indirect) | View |
| 2022-08-30 Other | 2022-09-01 5:22 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,604,027 (Indirect) | View |
| 2022-08-24 Other | 2022-08-26 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,545,681 (Indirect) | View |
| 2022-08-18 Other | 2022-08-22 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 958,162 (Indirect) | View |
| 2022-08-12 Other | 2022-08-16 9:05 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,587,519 | $0 | 1,987,335 (Indirect) | View |
| 2022-07-05 Option Award | 2022-07-07 4:30 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director | 266 | $0 | 44,055,496 (Direct) | View |